Fingerprint
Dive into the research topics of 'Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mark J. Ratain, Tim Eisen, Walter M. Stadler, Keith T. Flaherty, Stan B. Kaye, Gary L. Rosner, Martin Gore, Apurva A. Desai, Amita Patnaik, Henry Q. Xiong, Eric Rowinsky, James L. Abbruzzese, Chenghua Xia, Ronit Simantov, Brian Schwartz, Peter J. O'Dwyer
Research output: Contribution to journal › Article › peer-review